ID   BL-9
AC   CVCL_N271
SY   BL9; BL 9; BL09; IARC/BL9; IARC/BL 09; IARC-BL9; IARC BL9; IARC BL 9
DR   cancercelllines; CVCL_N271
DR   Cosmic; 2804857
DR   Wikidata; Q54797261
RX   PubMed=3934070;
RX   PubMed=6825067;
RX   PubMed=8108117;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: African.
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Thr73Ile (c.218C>T); ClinVar=VCV000376300; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=6825067; DOI=10.1016/0165-4608(83)90138-3;
RA   Bernheim A., Berger R., Lenoir G.M.;
RT   "Cytogenetic studies on Burkitt's lymphoma cell lines.";
RL   Cancer Genet. Cytogenet. 8:223-229(1983).
//
RX   PubMed=8108117;
RA   Albert T., Urlbauer B., Kohlhuber F., Hammersen B., Eick D.;
RT   "Ongoing mutations in the N-terminal domain of c-Myc affect
RT   transactivation in Burkitt's lymphoma cell lines.";
RL   Oncogene 9:759-763(1994).
//